The Russian healthcare sector’s degree of concentration differs between segments. While the healthcare service sector is mainly government-owned, with limited participation of private clinics and other healthcare institutions, the pharmaceutical and medical equipment segments are highly competitive, with international companies being the top players in both segments. On the other hand, the drug retail chains and drug distribution sectors are concentrated among a few market players, mainly with Russian origin. There has been a consolidation trend in the Russian pharmaceutical market. As a result, the share of the top 20 players in total sales increased to 51% in 2017 from about 25% in 2014, according to data provided by local pharmaceutical market research company DSM Group.

01 EXECUTIVE SUMMARY 

02 SECTOR IN FOCUS 

03 COMPETITIVE LANDSCAPE

04 COMPANIES IN FOCUS 

05 REGULATORY ENVIRONMENT 

06 PHARMACEUTICALS 

07 MEDICAL EQUIPMENT